悦心健康(002162.SZ):半年度淨利潤預盈1.55億元-1.75億元 同比扭虧
格隆匯6月16日丨悦心健康(002162.SZ)公佈2023年半年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利1.55億元–1.75億元,同比扭虧為盈;扣除非經常性損益後的淨利潤虧損100萬元–盈利1000萬元;基本每股收益盈利0.1673元/股–0.1889元/股。營業收入5.5億元-6.5億元比上年同期增長10%-30%。
業績變動情況:
1、報吿期主營業務瓷磚銷售收入較去年同期增長約15%,投資性房地產租賃業務收入較去年同期增長約10%;
2、公司於去年終止了負離子健康材料業務以及剝離不良資產也降低了對經營業績的負面影響,減少了今年公司經營性虧損;
3、預計報吿期非經常性損益對淨利潤的影響金額為15,600萬元至16,500萬元,主要系報吿期內公司轉讓全資子公司上海悦心健康科技發展有限公司股權後喪失控制權,認列股權轉讓相關收益約16,200萬元(税前),其中自用房產轉投資性房地產時形成的對應綜合收益部分,由於處置股權,確認當期收益約9000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.